Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Sentinel Dosing—Time for a Risk‐Based Approach?
Sentinel Dosing—Time for a Risk‐Based Approach?
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Peter L. Bonate
,
Mark Rogge
,
Jean‐Michel Gries
,
Alexander J. Prokopienko
,
Sudhakar M. Pai
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
The Journal of Clinical Pharmacology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
ACCP Position Statement on Unregulated Psychotropic Products
by: Tao Long, et al.
Published: (2024)
Physiologically Based Pharmacokinetic (PBPK) Model to Predict the Magnitude of Drug–Drug Interaction Between Fezolinetant and CYP1A2 Inhibitors
by: Mary P. Choules, et al.
Published: (2025)
Reframing Non‐Traditional PharmD Career Opportunities Across Drug Development, Regulatory, and Academia
by: Michael Nome, et al.
Published: (2026)
Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study
by: Alexander J. Prokopienko, et al.
Published: (2024)
In Vitro Evaluation of CYP‐Mediated Metabolism of Fezolinetant and Pharmacokinetic Interaction Between Fezolinetant and Fluvoxamine in Healthy Postmenopausal Smokers and Nonsmokers
by: Megumi Iwai, et al.
Published: (2024)